Table 1 Clinicopathological parameters for the clinical tumour set
Number | Percentage | |
|---|---|---|
Tumour grade | ||
Grade 1 | 2 | 2.6 |
Grade 2 | 29 | 37.7 |
Grade 3 | 43 | 55.8 |
Not known | 3 | 3.9 |
Oestrogen receptor status | ||
Positive | 46 | 59.7 |
Negative | 31 | 40.3 |
Epidermal growth factor receptor (membrane) status | ||
Positive | 43 | 55.8 |
Negative | 31 | 40.3 |
Not known | 3 | 3.9 |
erbB2 (membrane) status | ||
Positive | 19 | 71.4 |
Negative | 55 | 24.7 |
Not known | 3 | 3.9 |
erbB3 (membrane) status | ||
Positive | 61 | 79.3 |
Negative | 9 | 11.7 |
Not known | 7 | 9.1 |
Menopausal status | ||
Premenopausal | 23 | 31.1 |
Postmenopausal | 51 | 68.9 |
Not known | 3 | 3.9 |
Site of disease | ||
Locally advanced | 29 | 39.2 |
Metastatic | 45 | 60.8 |
Not known | 3 | 3.9 |
Ki-67 index | ||
0 | 10 | 13 |
<10 | 15 | 19.5 |
10–30 | 52 | 67.5 |